PMV Pharmaceuticals
PMVP
PMVP
99 hedge funds and large institutions have $72.7M invested in PMV Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
8.52% less ownership
Funds ownership: 91.61% → 83.09% (-8.5%)
50% less capital invested
Capital invested by funds: $145M → $72.7M (-$72.6M)
71% less call options, than puts
Call options by funds: $6K | Put options by funds: $21K
Holders
99
Holding in Top 10
1
Calls
$6K
Puts
$21K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$2.22M | |
| 3 | +$1.11M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$824K |
| 5 |
D.E. Shaw & Co
New York
|
+$803K |
Top Sellers
| 1 | -$6.48M | |
| 2 | -$5.55M | |
| 3 | -$2.35M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.13M |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$2.13M |